BioPharm America 2012

Beginning its fifth year as an industry event, BioPharm America creates a robust exchange among hundreds of executives from venture capital firms, major pharmaceutical companies, academic institutions and biotechnology companies of every size from mature to start-up.

It is a pure partnering event focused on one-to-one meetings driven by the partneringONE® software platform that schedules meetings and provides each participant with a dynamic personalized agenda and regular alerts for further meeting opportunities.

The backdrop for this intensive business development activity is a three-day conference program that features leading executives from across the life science industry. At BioPharm America held in Boston in September 2011, panel discussions included licensing, investment and business development executives from Amgen, AstraZeneca, Bayer HealthCare, Biogen Idec, Genentech, Genzyme, Gilead, Ironwood, Janssen Global Services, Merck, Nycomed, Pfizer, and Shire. The event attracted 950+ delegates from 588 companies who participated in 2,550+ scheduled one-to-one meetings.

BioPharm America 2011 Highlights
- 2,550 one-to-one meetings
- 950+ delegates
- 760 licensing opportunities
- 588 companies
- 82 company presentations
- 34 countries represented
- 22 exhibitors
- 21 workshops and panels

Intended For
Top international executives from:
- Established and emerging biotech companies
- Pharmaceutical companies
- Institutional financial firms
- Private investors including venture capital and private equity firms
 

Medicon Valley will be represented at BioPharm America 2012 by:
Copenhagen Capacity
Ruth Klyver
Business Development Manager, Life Science
Tel.: +45 33 26 87 15
E-mail: rk@copcap.com

Invest In Skåne
Lovisa Sunesson
Business Development Manager, Life Science
Tel: +46 40 675 30 01
E-mail: invest@skane.com

For registration,
please visit: www.ebdgroup.com/bpa/registration